We evaluated survival by baseline ( 1993-2001 ) self-reported diabetes history ( n = 62 ) among 504 participants that developed exocrine pancreatic cancer within the Prostate , Lung , Colorectal , and Ovarian ( PLCO ) Cancer Screening Trial .